Tower Research Capital LLC (Trc) Armata Pharmaceuticals, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.29 Billion
- Q1 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Armata Pharmaceuticals, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,471 shares of ARMP stock, worth $6,525. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,471
Previous 3,312
4.8%
Holding current value
$6,525
Previous $6,000
16.67%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding ARMP
# of Institutions
28Shares Held
740KCall Options Held
300Put Options Held
1K-
Vanguard Group Inc Valley Forge, PA260KShares$488,9370.0% of portfolio
-
Geode Capital Management, LLC Boston, MA106KShares$198,9730.0% of portfolio
-
Edgewood Management LLC Greenwich, CT100KShares$188,0000.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX44.7KShares$84,0020.0% of portfolio
-
State Street Corp Boston, MA40.3KShares$75,7640.0% of portfolio
About Armata Pharmaceuticals, Inc.
- Ticker ARMP
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,144,700
- Market Cap $68M
- Description
- Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus ...